Some people lose muscle during GLP-1 treatment because appetite drops, total food intake decreases, and protein intake may become too low
Chronic, worsening fatigue is a red flag
But others may be able to maintain results by transitioning to a low-maintenance dose, by spacing out the injection frequency, by transitioning to a different anti-obesity medication, oras weve seen in parallel spaces like diabetes and high blood pressure that also rely heavily on medicationby discontinuing medication altogether while leaning into lifestyle changes. Calibrate advisor Dr
and long-acting GLP-1 RAs, including exenatide once-weekly, liraglutide, albiglutide, dulaglutide, and semaglutide, known for providing more consistent glycemic control 48,49
In vitro assays show relatively balanced GLP-1 and glucagon receptor activity, with stronger GIP receptor potency reported in some assay systems
They are not for human consumption, medical treatment, diagnosis, or disease prevention